Max Robotics — Global Service Robot Directory + US Certification

About

Dae Yong Kim is a leading colorectal surgeon whose research has significantly advanced the surgical management of rectal cancer, particularly through the integration of robotic technology and optimized neoadjuvant therapy. His most impactful work, a phase II randomized controlled trial comparing robot-assisted versus laparoscopic surgery for rectal cancer (335 citations), established critical evidence on the feasibility and short-term outcomes of robotic approaches, challenging conventional laparoscopic standards. Building on this, his case-matched study evaluating robotic surgery after preoperative chemoradiotherapy (62 citations) demonstrated the safety and potential advantages of robotics in complex, irradiated pelvic anatomy. Beyond surgical technique, Kim has contributed to refining multimodal treatment protocols, as shown in his phase II multi-institutional trial of a two-week chemoradiotherapy course followed by delayed surgery (25 citations), which explored dose-intensified regimens to improve tumor response. With over 400 cumulative citations, Kim’s work bridges surgical innovation and oncologic precision, offering surgeons and patients evidence-based pathways for minimally invasive rectal cancer care. His leadership in the Korean Radiation Oncology Group trials underscores his role in shaping multidisciplinary treatment standards.